Active recording of adverse events after COVID-19 vaccination - feasibility study

Conditions

Vaccination

Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S, Warkentin L.

2023-09-192 citations

Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study.

Warkentin L, Werner F, Zeschick N, Kühlein T, Steininger P, Überla K, Kaiser I, Sebastião M, Hueber S.

2023-06-202 citations

10.1186/s12916-023-02924-5

Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project.

Zeschick N, Warkentin L, Kühlein T, Steininger P, Überla K, Hueber S, Sebastião M.

2022-07-024 citations

10.1186/s40814-022-01088-y

Interventions

Group 1: Focus groups with (vaccinated) persons to evaluate comprehensibility, visual design of the recruitment material and online survey, and technical correctness of the online survey Group 2: Inte

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: vaccination status irrelevant for focus groups/interviews; COVID-19 oder control vaccination for onlie-survey

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Selection of suitable materials and process for recruitment; development of and comprehensible and technically feasible online survey;	—

Countries

Germany

Contacts

Public ContactMaria Sebastiao

Universitätsklinikum Erlangen Allgemeinmedizinisches Institut

Maria.Sebastiao@uk-erlangen.de+49 (09131) 85-45761

Outcome results

None listed